Gault Cheryl
- SEC CIK
- 0001839046
In the past year, 5 open-market sale filings worth $1.24M and no purchases.
Current role at each company
- RAPP Rapport Therapeutics, Inc.Chief Operating Officeras of Oct 1, 2026
- KRSA Korsana Biosciences, Inc.Chief Operating Officeras of Jan 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.24M
- 5 filings
- Net
- −$1.24M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gault Cheryl as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RAPP Rapport Therapeutics, Inc.
Chief Operating Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2025 (view filing) | Sep 8 | 2 days | Gault CherylChief Operating Officer | SSale | −5.00K | $38.33 | −$191.7K | −2.8%171.9K after | 10b5-1 |
| Dec 1, 2025 (view filing) | Nov 26 | 5 days | Gault CherylChief Operating Officer | SSale | −5.00K | $30.10 | −$150.5K | −2.8%171.9K after | 10b5-1 |
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Gault CherylChief Operating Officer | SSale | −2.01K | $28.93 | −$58.3K | −1.2%169.9K after | |
| Mar 31, 2026 (view filing) | Mar 30 | 1 day | Gault CherylChief Operating Officer | SSale | −10.0K | $28.18 | −$281.8K | −5.9%159.9K after | 2 lots10b5-1 |
| Jul 1, 2026 (view filing)4:10 PM ET | Jun 30 | 1 day | Gault CherylChief Operating Officer | SSale | −10.0K | $41.58 | −$415.8K | −6.3%149.9K after | 4 lots10b5-1 |
| Oct 1, 2026 (view filing)4:30 PM ET | Sep 30 | 1 day | Gault CherylChief Operating Officer | SSale | −10.0K | $33.19 | −$331.9K | −6.7%139.9K after | 2 lots10b5-1 |